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Abstract
Significance: The environment can elicit biological responses such as oxidative stress (OS) and inflammation as
a consequence of chemical, physical, or psychological changes. As population studies are essential for estab-
lishing these environment-organism interactions, biomarkers of OS or inflammation are critical in formulating
mechanistic hypotheses.
Recent Advances: By using examples of stress induced by various mechanisms, we focus on the biomarkers
that have been used to assess OS and inflammation in these conditions. We discuss the difference between
biomarkers that are the result of a chemical reaction (such as lipid peroxides or oxidized proteins that are a
result of the reaction of molecules with reactive oxygen species) and those that represent the biological response
to stress, such as the transcription factor NRF2 or inflammation and inflammatory cytokines.
Critical Issues: The high-throughput and holistic approaches to biomarker discovery used extensively in large-
scale molecular epidemiological exposome are also discussed in the context of human exposure to environ-
mental stressors.
Future Directions: We propose to consider the role of biomarkers as signs and to distinguish between signs that
are just indicators of biological processes and proxies that one can interact with and modify the disease process.
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Biomarkers of Inflammation and Oxidative Stress
The theory that oxidative stress (OS)—an imbalancebetween production of toxic oxygen species, reactive
oxygen species (ROS), and endogenous antioxidants (164)—
may be at the basis of a disease was first put forward by
Harman in 1956 with the ‘‘free radical theory of aging,’’ in
which he concluded, ‘‘This theory is suggestive of chemical
means of prolonging effective life (64).’’ Despite this, there
are no antioxidants currently approved by regulatory agencies
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for any disease (59), with the possible exception of edaravone,
an antioxidant approved in Japan and India for aiding neu-
roprotection in stroke patients (96).
Inflammation is also postulated as a pathogenic mecha-
nism in most diseases or as a major risk factor (44). Its oldest
definition is by Aulus Cornelius Celsus in the first century
AD, who defined the four hallmarks of inflammation: ‘‘rubor,
et tumor, cum calore, et dolore,’’ redness, swelling, heat,
and pain (29). These are, for Celsus, ‘‘notae vero in-
flammationis.’’ ‘‘Notae’’ is usually translated in English with
‘‘signs’’ (‘‘the cardinal signs of inflammation’’). This is our
first encounter, in our review, of the concept of biomarkers.
In a way, biomarkers are ‘‘signs.’’ The father of semiotics,
Charles Sanders Peirce, described a semiotic triad where he
defines the relationship between a sign, the object it stands
for, and the interpretant (9). This concept is shown in Fig-
ure 1, where when the interpretant sees smoke, she knows
that that sign indicates that somewhere there is a wildfire.
From Celsus’ perspective, the signs of inflammation were
viewed mainly with a diagnostic or classification purpose.
However, in clinical and preclinical studies, as well as in
epidemiological studies, biomarkers are also used to gain
insights into the causal mechanisms underlying diseases.
Biomarkers have been classified into biomarkers for the eti-
ology of the disease (risk factors; including biomarkers of
exposure), and biomarkers of disease used in the screening
or diagnosis, or to monitor disease progression (prognosis)
(116). Even if not implicit in their definition, one desirable
criterion for a biomarker is to be accessible—that is, mea-
surable in biological fluids that can be obtained in a mini-
mally invasive manner (such as urine, blood, or synovial
fluid). In animal models, biomarkers can also be measured
in tissues and organs, possible only in human patients in the
few cases where biopsy samples are obtained for diagnostic
purposes.
The study of diseases can, in its turn, lead to the definition
of new biomarkers and to the refinement of the criteria for
disease classification. For instance, an inflammatory response
often results in tissue damage (e.g., joint damage in arthritis)
and loss of function, the ‘‘functio laesa’’ described by Galen
(145). The study of the molecular mechanisms of inflam-
mation led to infiltration of white blood cells, their recruit-
ment in the tissues as a result of inflammatory mediators
known as chemokines (197), being considered an additional
criterion of inflammation, more than the classical cardinal
signs. Cytokines and chemokines, inflammatory mediators
that are causative of many features of inflammatory diseases,
including the old five cardinal signs, are now used as bio-
markers of inflammation.
The identification of cytokines as mediators of inflammation
in the mid 1980s led to what Tracey called the ‘‘cytokine theory
of disease’’ (176). Contrary to the OS theory of disease, this led
to major advances in the treatment of chronic inflammatory
diseases, and less than 15 years after the identification of the
cytokine tumor necrosis factor-a (TNF-a), anti-TNF-a anti-
bodies were approved in the therapy of chronic inflammatory
diseases and are now the top-selling biologicals.
Here, we review both biomarkers of OS and inflammation;
this is not a random choice, as the two fields are tightly linked.
ROS can activate the transcription factor nuclear factor kappa
B (NF-jB) (156), which has many inflammatory cytokines
among its target genes. Conversely, inflammation can induce
OS (147), as, for instance, in the case of ROS production by
polymorphonuclear neutrophils (125).
Although the two pathways are so intertwined, they pres-
ent entirely different challenges in terms of biomarkers.
When studying disease mechanisms, we want to be able to
measure the effectors of inflammation. The development of
anti-TNF-a drugs was possible as researchers could measure
TNF-a levels in patients with commercially available im-
munoassays that detect TNF-a in stored blood samples.
All this is very difficult when studying OS in disease. Here,
the effector molecules are ROS, which have short half-lives,
ranging from nanoseconds to milliseconds (85). This makes it
impossible to measure ROS in biological samples and we
must rely on signs, chemicals that are produced by the in-
teraction of ROS with various cellular molecules (57).
Another important aspect to consider is the difference
between biomarkers that measure the formation of the ef-
fector molecule and those that measure the response of the
organism to an inflammatory stimulus; inflammation is a
defense/repair reaction of the organism to an infection or
injury. The process is complex, as the effector cytokines in
inflammation are produced after a series of steps. As men-
tioned earlier, there are several biomarkers of OS that in-
dicate the exposure of the organism to ROS by measuring
oxidative breakdown products of cellular molecules. How-
ever, exposure to OS can be inferred by measuring the
cellular defense response to it and, in this review, we will
give the example of the transcription factor nrf2/antioxidant
response element (ARE) transcription factor that is acti-
vated by ROS and other electrophiles. There are many ways
in which environmental stressors induce disease by com-
mon pathways (39, 123). The sections in this review will
deal with psychological, environmental, or noise-induced
stress, trying to focus on how their effects on inflammation
or OS were detected.
FIG. 1. The semiotic triad according to Peirce. Images
from Wikimedia Commons.




















































Engineered Nanomaterials as Environmentally Borne
Agents Inducing Inflammation and OS
Engineered nanomaterials (ENM) are manufactured ma-
terials in which at least one dimension is in the nanometer
range (<100 nm). The higher surface area increases the
material’s reactivity (126). Redox interactions of ENM are
major mechanisms of toxicity, particularly for metal and
metal oxide nanomaterials, quantum dots, and carbon
nanotubes (CNT).
Typically, OS is induced by ENM in a three-tiered hier-
archical sequence (Fig. 2) (126, 131). A mild production of
ROS induced by ENM (Tier 1) lowers the reduced glutathi-
one (GSH)/oxidized GSH (GSSG) ratio and upregulates
genes encoding type II anti-oxidant enzymes, thus re-
establishing homeostasis. In Tier 2, the defensive reaction is
more complex; ENM induce the production of ROS, trig-
gering the production of inflammatory cytokines and che-
mokines. However, the inflammatory response is transient, as
the elimination of the triggering event (e.g., the phagocytosed
ENM) and inflammation-damping feedback mechanisms re-
establish homeostasis. In Tier 3, the GSH/GSSG ratio is
completely imbalanced and essential components of cells are
damaged, causing genotoxicity and cytotoxicity.
This sequence does not distinguish between the capacity of
ENM to generate ROS in cell-free systems (131) and ROS
generation consequent to nano-bio interaction. In a complex
system (tissue, organ), a different three-pronged model can
be proposed for the inflammatory response to ENM (Fig. 3).
In this model, Prong 1 represents the lack of response, due to
either ‘‘ignorance’’ or ‘‘tolerance,’’ in which the living sys-
tem eliminates ENM immediately, for example, by excretion
with urine. Prong 2 is the classical protective inflammatory
response, in which a tissue reacts to ENM while sending
alarm signals, with recruitment of blood immune cells to
eliminate the ENM. The reaction is, however, limited in time
and circumscribed; after eliminating the ENM, inflammation
is resolved. Prong 3 is the pathological situation of an in-
flammatory reaction that cannot be resolved, as in the case of
persistent materials (e.g., fiber-like particles). This may result
in persistent inflammation with tissue destruction and de-
velopment of non-functional neo-tissue (granuloma, scarring
tissue, pannus, fibrotic tissue). Only Prong 3 can be eventu-
ally harmful for the organism and cause irreparable damage.
The three-tiered model of ENM-induced OS does not re-
flect the three-pronged model of ENM-induced inflammation
because the entire organism considers the death of single
cells as an acceptable event that may be important in the
‘‘cleaning’’ and healing reaction.
ROS production by nanomaterials
Unstable ENM can undergo oxidation, reduction, and
dissolution in biological media, releasing reactive-free ions
(in the case of metal ENM such as silver), or excitation of
electrons and generation of ROS (as in the case of titania
ENM and fullerenes on UV irradiation). In addition, the re-
active surface of ENM may absorb transition metals that
catalyze ROS-generating reactions (Fenton, Fenton like,
Haber-Weiss) and produce cytotoxic and genotoxic hydroxyl
radicals (126, 131, 137). Production of ROS resulting from
the interaction of ENM with living systems is mainly indirect,
due to damage or alterations caused by ENM to membranes,
which trigger an alarm inflammatory reaction.
The production of ROS is one of the defensive mecha-
nisms initiated by innate defense cells such as phagocytes,
aiming at killing microorganisms. Silica and polycationic
particles can interact with plasma membrane phospholipids,
leading to membrane destabilization and ROS production (3,
103). Urate crystals can also bind plasma membrane cho-
lesterol and lead to aggregation of receptors and other mol-
ecules within lipid rafts, thus activating Syk-dependent
inflammatory signaling and ROS generation (128, 202). ROS
induction can also be indirect, as, for instance, in the case of
crystalline silica particles that can induce TNF-a production
that stimulates ROS generation (15). Once internalized, ENM
can destabilize and rupture the membranes of organelles such
as phagolysosomes and mitochondria, causing ROS pro-
duction and inflammation.
High-aspect ratio ENM (rigid fiber-like or needle-like
ENM) are particularly challenging for phagocytes and gen-
erate a phenomenon known as ‘‘frustrated phagocytosis,’’
with waves of phagocytes attempting to take up the material,
and persistent inflammation, including ROS production. ROS
production induced by ENM is in most cases associated with
FIG. 2. The three-tiered paradigm of OS induced by
nanomaterials at the single-cell level. OS, oxidative stress.
FIG. 3. The three-pronged response of complex living
systems to nanomaterials.




















































Akt/mTOR pathway, autophagy, and apoptosis (5). This can
evolve into a Tier 3 reaction, with ROS production inducing
lipid peroxidation, membrane destabilization, and DNA and
protein damage. Rigid needle-like ENM can also cause phago-
cyte death by literally perforating the cell membrane (121).
Unlike apoptosis, necrotic cell death implies membrane
damage and the release of intracellular components, which
perpetuates the inflammatory reaction (187). This may lead
to tissue damage or, in a ‘‘pathological’’ attempt to contain
the danger, can result in fibrotic or granulomatous reactions
(Prong 3). In some cases, leukocytes can successfully de-
grade high-aspect ratio EMN without phagocytosing them, as
in the case of multi-walled CNT, which are sensitive to
several leukocytic enzymes, and can, therefore, be eliminated
rapidly without causing excessive ROS-mediated tissue
damage (183). This would, therefore, be a classical Prong 2
inflammatory reaction that is resolved without causing per-
manent damages.
Inflammatory reactions induced by nanomaterials
Inflammation (Prong 2) is, therefore, a central event in
ENM-induced OS (24). At the organism level, inflammation
is a defensive mechanism that succeeds in tagging and
eliminating potentially dangerous agents (including ENM).
Inflammation, however, always induces some collateral
damage, that is, the death of some cells (including both the
effector cells and innocent bystanders). In terms of ENM
cytotoxicity, at the single-cell level, inflammation can be in
Tier 2 (resolves without cell death) or in Tier 3 (ending with
cell death). Both events can be included in Prong 2, an in-
flammatory reaction at the tissue/organ/organism level that
succeeds in eliminating the danger despite some cell death
and tissue damage, and that succeeds in repairing the col-
lateral damage and restoring functionality. Tier 2 and Tier 3
cellular reactions, on the other hand, are also included in
Prong 3, the unresolving inflammation that fails in re-
establishing tissue homeostasis, so that organ function is
eventually compromised.
One aspect of ENM-induced inflammation is the capacity
of activating the inflammasome, in particular NLRP3, which
is the main inflammasome complex. This is a complex of
proteins that assembles in the cytoplasm in response to in-
flammatory stimuli and leads to the activation of the enzyme
caspase-1, which is responsible for cleavage and activation
of the precursor forms of two important inflammatory cyto-
kines, interleukin (IL)-1b and IL-18 (82). Caspase-1 can also
auto-activate and mediate cell death (172). Several studies
have shown that ENM can activate the NLRP3 inflamma-
some [reviewed in Sun et al. (171)], similarly to other par-
ticulate agents (e.g., hydroxyapatite crystals, cholesterol
crystals, and aluminum hydroxide particles) (52, 74, 83).
Inflammasome activation by ENM can occur through dif-
ferent mechanisms, including generation of ROS, which
participate in inflammasome activation (63, 190).
Another mechanism is the destabilization of phagolyso-
somal membranes with consequent release of lysosomal en-
zymes, in particular cathepsin B, that activate the
inflammasome either directly or via ROS (82). Other putative
mechanisms of ENM-induced inflammasome activation in-
clude activation of the NADPH oxidases (NOX), K+ efflux,
purinergic receptor P2X7 (P2X7R)-mediated ATP depletion,
decrease of mitochondria membrane potential, and
thioredoxin-interacting protein (TXNIP)-induced NALP3
activation (82, 148). A summary of typical data of ENM-
induced NLRP3 inflammasome activation is presented in
Table 1. The general conclusion is that crystals and high-
aspect particles (such as fibers) are excellent activators of the
inflammasome. However, since inflammasome activation is
not per se a sign of toxicity or pathological inflammation, it is
a reaction that can be included both in Prong 2 and in Prong 3,
and only a deeper kinetic analysis may allow us to discrim-
inate between protective and pathological activation.
A final note of caution, when studying OS and inflamma-
tion induced by RNM, regards the possibility that ENM are
inadvertently contaminated with endotoxin. This is a very
common event when ENM synthesis and handling are not
carried out in endotoxin-free conditions (180). The presence
of endotoxin can cause per se inflammation that may be er-
roneously attributed to ENM (106).
Induction of OS and inflammation by particulate matter
All that has been said earlier for ENM applies as well to
particulate matter (PM) collected from the environment. In-
deed, studies on the capacity of PM to induce OS and in-
flammation are extensive and date back many years. Diesel
exhaust particles (DEP), concentrated ambient particles, and
ultrafine particles are some of the many types of PM that have
been extensively studied in this direction [see, for instance, Li
et al. (105)]. Although many studies show that PM can induce
significant pulmonary inflammation on inhalation in vivo,
still we are unable to associate PM characteristics with the
ability to induce OS and inflammation. In fact, ambient PM
is typically morphologically and chemically heterogeneous,
very much depending on the specific environmental condi-
tions (such as temperature and humidity) and concomitant
emissions.
In addition, the presence of biologically active molecules
such as bacterial lipopolysaccharide (see earlier for ENM) is
practically never tested in the many studies published so far
[see, for instance, Ying et al. (204)], leaving open the pos-
sibility that several of the effects caused by PM can be at-
tributed to the presence of bacterial moieties, which typically
trigger the same OS and inflammatory effects. Thus, the PM
ability of inducing OS and inflammation is most likely the
result of intrinsic toxicity of the chemicals present in the PM,
of its state of aggregation and consequent changes in mor-
phology (which may cause mechanical stress to cells), and of
the presence of bystander biological substances (such as
pollens, animal allergens, and bacterial fragments of whole
micro-organisms). In this context, although we can list many
biomarkers of both OS and inflammation induced by inha-
lation of PM, it is impossible to associate any of them to
particle-specific effects.
NRF2 as an Indicator of Response to OS
One approach to monitoring OS as well as environmental
electrophilic chemicals is to use biomarkers based on the
response of the organism, as opposed to measuring oxidized
products of cellular components. NRF2 is the main tran-
scriptional regulator of cellular homeostasis and protects
against multiple stress conditions. On dimerization with small
MAF proteins, it recognizes an enhancer in the promoter




















































region of target genes, termed ARE/electrophile responsive
element (EpRE) genes. These account for about 1% of human
genome and encode phase I, II, and III detoxification en-
zymes, GSH, peroxiredoxin (PRDX) and thioredoxin (TXN)
metabolism, intermediary metabolism related to pentose
phosphate pathway, etc. (67).
The main mechanism of regulation is protein stability by
the ubiquitin/proteasome system (UPS) illustrated in Fig-
ure 4. Under non-stress conditions, the E3 ubiquitin ligase
adapter Kelch-like ECH-associated protein 1 (KEAP1)
drives NRF2 to ubiquitination by the Cul3/RBX complex and
rapid proteasomal degradation. However, KEAP1 contains
several cysteine residues that have a low pKa value, making
them highly suited for acting as a sensor for oxidative and
electrophilic stress (112). Oxidant or electrophilic modifica-
tion of critical cysteines in KEAP1, mainly C155, C273, and
C288, prevents the protein from connecting NRF2 to the
UPS, thus resulting in the accumulation of nuclear NRF2 and
transcriptional activation of ARE genes.
Another crucial mechanism for control of NRF2 stability is
by phosphorylation. Several kinases phosphorylate NRF2
with different outcomes. Activating phosphorylation by MAP
kinases, PKC or PERK at Ser40, and other residues appears to
free NRF2 from KEAP1 control. On the other hand, the Ser/
Thr protein kinase glycogen synthase kinase 3 (GSK-3)
phosphorylates at least Ser 335 and 338 in murine NRF2,
thereby creating a recognition site for the E3 ubiquitin ligase
adapter b-TrCP, leading to ubiquitination by Cul1/RBX and
proteasome degradation of NRF2 (40, 141, 142). Importantly,
several phosphatases, such as phosphatase and tensin ho-
molog (PTEN), contain thiol reactive cysteines in their cat-
alytic center, which become inactive on oxidation or reaction
with electrophiles (139, 149). In this case, PTEN inhibition
leads to sustained activation of AKT and inhibition of GSK-3.
As a result, NRF2 escapes GSK-3/b-TrCP-mediated degra-
dation (40). Later, we will discuss advances on its role for
protection against several environmental forms of stress.
Heavy metals
Occupational or environmental exposure to heavy metals
generates OS that, depending on the route of entrance and
Table 1. Inflammasome Activation Induced by Particles Versus Engineered Nanomaterials
Material Main findings References
MSU crystals NLRP3-dependent induction of IL-1b release in vitro (115)
Cholesterol crystals Cholesterol crystals activate NLRP3 and induce IL-1b production in
human macrophages
(52, 143)
Hydroxyapatite crystals Induction of IL-1b and IL-18 production in mouse macrophages is induced
by needle-like and clumped nanocrystals, but not spherical and larger
crystals, and depends on potassium efflux, generation of ROS, and
lysosomal damage/cathepsin B in vitro, and on various NLRP3
components in vivo (knockout mice)
(83)
Crystalline silica Crystalline silica induces NLRP3 activation and IL-1b production through
phagolysosome destabilization
(50, 74, 195)
Amyloid b Induction of IL-1b release in vitro in LPS-primed primary mouse microglial
cells, NLRP3 inflammasome dependent, and ATP dependent
(61)
Asbestos Asbestos induces NLRP3 inflammasome activation in vitro (human primary
macrophages), dependent on ROS production, cathepsin B activity,
P2X7Rs, and Src/Syk kinases
(50, 132)
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Smaller particles are taken up better by mouse BMDC in vitro and induce
more IL-1b release, in an NLRP3-, cathepsin B-, and phagosomal
acidification-dependent manner
(159)
Silver nanospheres Smaller particles induce IL-1b release in monocytes better than larger ones,
dependent on mitochondrial superoxide, cathepsin release, and K+ efflux
(201)
TiO2 nanobelts Induction of IL-1b release in vitro by long but not by short or spherical
particles (human THP-1, murine alveolar macrophages)
(62)
TiO2 nanospheres Phagocytosis-independent induction of IL-1b release in vitro (mouse BMDM,
human THP-1 and primary keratinocytes). Smaller particles more active
than larger ones in murine DC, in an actin-, ROS-, NLRP3-, and
caspase-1-dependent fashion.
(195, 203)
SiO2 nanospheres Phagocytosis-independent induction of IL-1b release in vitro (mouse
BMDM, human THP-1, and primary keratinocytes). Amorphous silica
NPs induce IL-1b production in mouse DC in an actin-, ROS-, NLRP3-,
and caspase-1-dependent fashion.
(195, 203)
Carbon nanotubes Long CNT induce NLRP3 inflammasome activation in vitro (human primary
macrophages), dependent on ROS production, cathepsin B activity,
P2X7R, and Src/Syk kinases
(132)
BMDC, bone marrow-derived dendritic cells; BMDM, bone marrow-derived macrophages; CNT, carbon nanotubes; IL, interleukin; LPS,
lipopolysaccharide; P2X7R, purinergic receptor P2X7; PLG, poly(d,l-lactide-co-glycolide); ROS, reactive oxygen species.




















































clearance, may produce liver, kidney, or lung damage among
others. Chromium, arsenic, cadmium, mercury, and lead can
interact with nucleophilic thiol groups, for example, cysteine
residues in proteins. Cells have a thiol buffering capacity
represented by the GSH and PRDX/TXN systems. Exposure
to heavy metals will compromise these systems and alter a
significant fraction of thiols in critical enzymes. Formation
of sulfur-metal bonds in redox-sensitive cysteines of KEAP1
will result in its stabilization. Also, signaling pathways are
altered, with phosphatases such as PTEN being inhibited,
resulting in increased activation of AKT, inhibition of GSK-
3, and further stabilization of NRF2. The result is upregula-
tion of genes involved in GSH synthesis and maintenance of
reduced TRX and GSH, both of which are important to tol-
erate metal exposure.
Furthermore, as reported for cadmium, chromium, arsenic,
and others, low-level chronic exposure to metals may induce
cancer. Somatic mutations in the interface of interaction between
KEAP1 and NRF2 have been correlated with several types of
tumors (162), and NRF2 levels are elevated in cancer cells,
resulting in a metabolic reprogramming that allows to withstand
OS and adverse growth conditions. It is, therefore, possible that
part of the tumorigenic activity associated with exposure to
heavy metals might be due to dysregulation of NRF2 (165).
Most of the exposure to heavy metals is in the form or
reactive molecules. For example, intracellular reduction of
hexavalent chromium generates highly reactive pro-oxidant
intermediates, together with superoxide, hydrogen peroxide,
and hydroxyl radical. These compounds irreversibly inhibit
TXN reductase and deplete TXN and PRDX (124). Although
this situation is typical of KEAP1 inhibition, it is also rec-
ognized that TXN depletion has additional effects on sig-
naling pathways such as activation of ASK1, leading to
upregulation of NRF2 by MAPK kinases by yet-unknown
mechanisms.
Noise injury
As expected, noise-induced OS also results in the activa-
tion of NRF2 and induction of some of its target genes, in-
cluding superoxide dismutase (SOD) and heme oxygenase
(54, 73). These studies also show that NRF2 deficiency in-
creases noise-induced injury and hearing loss, whereas its
induction has protective effects (54, 73).
Exposure to PM
Similar to other forms of environmental stress, exposure to
PM results in activation of NRF2 and increased transcription
of its target genes (48, 77). NRF2 induces not only tran-
scription of antioxidant genes but also in phase 2 enzymes of
xenobiotic metabolism. As a consequence, NRF2 deficiency
increases the genotoxic actions of diesel exhaust (6). This has
led to the suggestion that the levels of expression of NRF2
target genes could represent markers of exposure to PM
(196). Because NRF2 also regulates secondary effects of
environmental pollutants, such as inflammation and allergy,
the NRF2 response to PM could also be used to predict those
at risk of developing asthma (104), cardiovascular disease
(CVD), and atherosclerosis (99).
Mental stress
Recent studies have correlated depression, typically
caused by mental stress and social defeat, with low-grade
chronic inflammation that affects critical regions of the brain
(14). NRF2 modulates inflammation by downregulating the
NF-jB pathway (41, 78). In addition, NRF2 inhibits ex-
pression of IL-6 and IL-1b by directly binding the proximal
promoter of these genes (90). Nrf2-knockout mice exhibit a
depressive-like behavior, with reduced levels of dopamine
and serotonin and increased levels of glutamate in the pre-
frontal cortex, altered levels of proteins associated to de-
pression such as VEGF and synaptophysin, as well as
microgliosis. Importantly, depressive-like behavior elicited
by endotoxin in wild-type mice could be attenuated with the
NRF2 activator sulforaphane (114).
Ionizing and UV radiation
Exposure to cosmic, ionizing radiations and UV radiation,
either from natural sources of from devices, represents a
significant challenge to homeostatic redox mechanisms and
FIG. 4. Regulation of NRF2 by protein stability. (A), KEAP1/NRF2 interaction. Thiol reactive groups in KEAP1
provide a mechanism for sensing the levels of ROS and electrophiles. (B) b-TrCP/GSK-3/NRF2 interaction. Phosphor-
ylation of NRF2 by GSK-3 provides a layer of regulation by signaling pathways and by electrophilic compounds and alters
the balance kinase/phosphatase, exemplified here with PTEN [modified from Schmidt et al. (154)]. GSK-3, glycogen
synthase kinase 3; KEAP1, Kelch-like ECH-associated protein 1; NRF2, nuclear factor (erythroid-derived 2)-like 2; PTEN,
phosphatase and tensin homolog; ROS, reactive oxygen species.




















































nucleic acids integrity. Recent studies have demonstrated that
NRF2 promotes DNA repair and drives detoxification of
superoxide that is generated after irradiation (158). In par-
ticular, NRF2 regulates the expression of RAD51, many
DNA repair genes, including those of homologous recom-
bination repair pathway, and have putative AREs (80).
Noise-Induced Hearing Loss
Noise-induced hearing loss (NIHL) can be induced by
exposure to loud sound. Affected individuals may have in-
ability to hear certain frequencies of sound, cognitive im-
pairment of sound perception, including sensitivity to sound
and ringing in the ears (tinnitus) (1). The association between
noise exposure and hearing loss was first recognized by Sir
Francis Bacon (1561–1626) (65).
NIHL is caused by acute (e.g., sudden exposure to loud
noise, explosion) or chronic acoustic trauma (e.g., loud mu-
sic). NIHL is the most common occupational disease and its
severity differs among individuals, and increases with age,
compromising the quality of life that extends beyond hearing
loss. Unfortunately, unlike birds and amphibians, the ability
to regenerate hearing is lost in mammals. Thus, in human
beings, any damage to the hearing organ from any sound
source over time leads to permanent hearing loss.
Cochlea is located within the inner ear and houses the
specialized peripheral end organ of the auditory system,
which mediates the transduction of sound waves into elec-
trical nerve impulses that travel to the brain for central pro-
cessing of auditory information. Acoustic insults to the
cochlea cause mechanical and metabolic changes affecting
almost all cell types, but particularly the sensory hair cells
and neurons. Temporary and permanent threshold shifts oc-
cur from mechanical and metabolic changes caused by the
exposure to different noise levels (34, 70, 92, 95, 100). Me-
chanical damages occur with exposure to the noise levels of
115–125 dB sound pressure level (SPL), whereas metabolic
damages occur with exposure to the noise level of less than
115 dB SPL. These changes in threshold shifts are related to
noise-induced neural degeneration, which begins shortly af-
ter noise exposure and can progress for several years post-
exposure (94, 119). Importantly, early noise exposure can
intensify age-related hearing loss (94).
Beginning at 85 dB (*300 times the energy level of
60 dB), long or repeated exposures may result in a notable
loss of hearing. This level of 85 dB and higher includes
some everyday sounds, for example, music on personal
listening devices or emanating from small machinery such
as lawnmowers. Noise coming from urban traffic, household
appliances, personal listening devices, or occupational
noise can also elicit hearing loss. Importantly, long or re-
peated exposure to moderate noise levels is often associated
with alterations in behavior, as well as with changes in
neuroendocrine, cardiovascular, and immune systems (45,
189). Cochlear damage and hearing loss associated with
chronic environmental noise exposure may be linked to an
increase in ROS levels as well as with inflammatory pro-
cesses in the cochlea.
NIHL: pathology
Early studies of NIHL demonstrated mechanical damages
of the cochlear structures, including the disruption of Re-
issner’s and basilar membranes, damage and loss of stereo-
cilia bundles, damage of the inner hair cells (IHCs) and outer
hair cells (OHCs), stria vascularis, spiral ganglion cells, and
lateral wall of the OHCs (23, 92, 100, 168). OS and inflam-
mation are major contributors to NIHL.
Cell death induced by acoustic overexposure occurs pri-
marily through apoptosis and necrosis. Apoptosis is a pro-
grammed cell death, with no inflammatory response (70). As
discussed later, the apoptosis can be mediated by the activity
of enzymes, induced by increased production of ROS and
reactive nitrogen species (RNS) (92, 129, 188). The second
cell death pathway is necrosis, a passive unprogrammed cell
death that is identified by swollen and pale-staining cyto-
plasm resulting in rupture of the cell, spillage of the cell
contents, damage to surrounding tissue, and evocation of an
inflammatory response (70). Both apoptotic and necrotic
pathways have been observed in the cochlea immediately
after noise exposure (76), as discussed later and illustrated
in Figure 5.
OS-induced apoptosis in hearing loss
The cochlea is a highly metabolically active sensory organ
that receives 0.5 ml/min of blood flow in normal conditions
(92). Metabolically, noise exposure can decrease cochlear
blood flow, leading to cochlear ischemia-reperfusion injury,
induce cell death by producing ROS, and contribute to injury
and death of hair cells and spiral ganglion cells (33, 70, 92).
Noise-induced OS causes lipid peroxidation in the spiral
ganglion, organ of Corti, and stria vascularis, leads to oxi-
dation of actin filaments of stereocilia and cell membrane
lipids, protein oxidation, damage to nuclear and mitochon-
drial DNA, swelling and degeneration of afferent nerve
endings, and release of toxic lipid peroxidation products such
as 4-hydroxy 2,3-nonenal (HNE) (51, 92).
OS biomarkers in hearing loss
OS occurs immediately and is present up to 30 days after
noise exposure (70, 200). In the first 10 days, the formation
of ROS reaches its peak (200). OS has been identified by a
variety of biomarkers of ROS and RNS activity in the cochlea
and the brain (51). These biomarkers include HNE, ni-
trotyrosine (NT), malondialdehyde (MDA), inducible nitric
oxide synthase (iNOS), cytochrome-C, caspase-3, -8, -9, and
p66shc. Formation of HNE was observed after noise expo-
sure in the lateral wall and Claudius cells, the Deiter’s cells,
and the OHC bodies (33, 51, 200). Formation of NT, a bio-
marker of NO production formed by nitration of a tyrosine
residue in proteins, occurs in the hair cells after noise exposure
(33, 51, 200). MDA was observed in cochlea immediately after
noise exposure (33). The expression of iNOS in the hair cells,
wall of the blood vessels of stria vascularis, and marginal cells
was observed immediately after noise exposure (160).
Noise exposure induces cytochrome-C release from mi-
tochondria and caspase-3, -8, or -9 activation in both apo-
ptotic and necrotic OHCs, whereas caspase activation occurs
only in apoptotic OHCs (129). Another important issue is the
cause of ROS production in NIHL. Animal studies have
shown that local application of NOX inhibitors has protective
effects (21), and a genome-wide association study (GWAS)
(98) showed that NOX3 is critical in the development of




















































NIHL. These studies led to the suggestion of a potential
therapeutic approach to inner ear pathologies (150).
Inflammatory biomarkers in hearing loss
Acoustic trauma can also initiate inflammation in the stria
vascularis, compromising blood supply to the cochlea and
causing hypoxia and injury to HCs (166). Injuries to the stria
vascularis and spiral ligament occur after noise trauma,
damaging type II and IV fibrocytes and leading to permanent
hearing loss (71).
As a response to acoustic trauma, the cochlear cells express
cytokines, such as TNF-a and IL-1b, and chemokines, which
cause leukocyte migration (86). These inflammatory cells,
producing cytokines, chemokines, ROS, and RNS, then
propagate the inflammatory process to the inner ear.
After acoustic trauma, an influx of inflammatory cells
occurs (71, 173, 174, 186). These cells are mostly found in
the spiral ligament (type I, III, and IV fibrocytes), and in the
perilymph of the scala tympani and scala vestibule (71, 173,
174, 186).). IL-6 immunoreactive cells were observed ini-
tially in the cytoplasm of type III and IV fIbrocytes, then
throughout the spiral ligament and the stria vascularis (58).
Double labeling with the neuronal marker NeuN showed IL-6
expression in the spiral ganglion neurons after noise expo-
sure. Chemokines (such as MCP-1/CCL2, MCP-5/CCL12,
and MIP-1b/CCL4) are upregulated by acoustic trauma
(174). ICAM-1/CD54, a vascular adhesion molecule that
mediates leukocyte extravasation, as well as other adhesion
molecules, including P-selectin, PECAM-1, and VCAM-1,
are also increased after noise exposure (161, 174, 199).
The measurement of cytokines as biomarkers on inflam-
mation in hearing loss may have translational implication.
For instance, the IL-1 receptor antagonist drug anakingra
improves hearing loss associated with autoinflammatory
diseases (120) and autoimmune diseases, including in glu-
cocorticoid (GC)-resistant patients (181).
Brain–Body Interactions of Stress, OS,
and Inflammation
Although stress and inflammation are often implicated in
disease, there is a bidirectional regulation between the two.
Figure 6 outlines the main regulatory pathways. The classical
pathway is mediated by GC. The fact that stress activates the
hypothalamus-pituitary-adrenal axis (HPAA) to increase GC
has been known for a long time, and GC are probably the
oldest anti-inflammatory drugs. The finding that GC inhibit
the expression of inflammatory cytokines provided an im-
portant mechanism of action (20). It soon became clear that
inflammatory cytokines activate the HPAA and, thus, in-
crease GC that not only inhibit cytokine synthesis but also
protect from their toxicity, in a classical feedback (18, 19, 35,
179). This raises an important point in the interpretation of
the scheme in Figure 6: Inflammatory cytokines and in-
flammation are also stressors themselves, sometimes defined
as ‘‘immune stressors.’’
It comes, therefore, as no surprise that corticosteroids are
used as biomarkers of stress. Because their levels in the blood
vary with time, the measurement of hair cortisol, which ac-
cumulates over weeks and months, has been proposed as a
FIG. 6. The main neuroendocrine-immune pathways.
FIG. 5. Mechanisms of ototoxicity induced by acoustic trauma.




















































biomarker of stress (117) and has been successfully used in
the study of post-traumatic stress disorder (PTSD) (111).
More recent studies have identified in the cholinergic re-
sponse mediated by vagus nerve stimulation another mech-
anism of regulation of peripheral inflammation by the brain,
which also led to the development of novel therapeutic op-
tions (133, 177).
The fact that infection induces a sickness behavior (leth-
argy, anorexia, social isolation) is an old observation, but
findings by Dantzer [reviewed in Dantzer et al. (47)] that this
is mediated by cytokines have provided a molecular mech-
anism for what is believed to be an adaptive response of the
organism to better survive an infection (46). Similar to their
effect on IL-1-induced lethality (19), GC inhibit the an-
orexigenic response to IL-1 (140), indicating that they act by
inhibiting not only cytokine production but also their action.
As mentioned earlier, OS can induce inflammation and,
vice versa, inflammation induces OS. This has been hy-
pothesized to be the case in PTSD, where a study measuring
levels of inflammatory cytokines and markers of OS suggests
that inflammatory cytokines induce ROS production, which
then amplifies the inflammatory response (194).
Fitting GC and the HPAA in this bi-directional auto-
stimulatory loop between inflammation and OS is more dif-
ficult. Clearly, GC, by blocking production of inflammatory
cytokines, could remove a major stimulus of OS. On the other
hand, activation of the HPAA, by increasing metabolic rate
and glucose availability, can result in increased OS (167) and,
in agreement with this hypothesis, administration of corti-
costerone to rats causes an increase in biomarkers of OS, lipid
peroxides, and protein carbonyls (153).
It should be pointed out, however, that the latter study as
well as the study on PTSD cited earlier (194) were performed
by measuring, among other biomarkers, superoxide levels in
plasma and blood. Because, as mentioned earlier, superoxide
has a half-life in milliseconds, some aspects of the method-
ological approach might be questioned.
Effect of emotional states on OS and inflammation
Emotions, inflammation, and OS share three fundamental
features: (i) They help the host to adjust to different envi-
ronmental challenges and maintain a status of homeostasis;
(ii) they can have both protective and deleterious effects for
the host; and (iii) they are deeply intertwined in ways that we
have only started to appreciate and are not fully explored. The
few examples given later should be sufficient to support these
statements.
There is evidence that basic emotions, such as laughter and
joy, improve immunological competence of the host through
natural killer cells, which are important in cancer surveillance
(60). It is possible that the negative emotional state often ex-
perienced after a diagnosis of cancer might contribute to the
development of this disorder, and that ‘‘laughing therapy’’ (60)
and patient support groups might have a biological therapeutic
value for cancer patients undergoing chemotherapy.
Negative emotions (anger and rage) can be protective as
they not only represent an immediate reaction to real or
imaginative dangers but also contribute to the exacerbation of
chronic inflammatory diseases (25, 88). Anger, rage, and
aggressive behavior cause a significant increase in the serum
levels of IL-1 (136).
Several studies (11, 26, 32, 42, 43, 113, 138) have high-
lighted the link between emotion and immunity.
Studies have shown how external conditions (massage-like
stroking or enriched environment) can improve the host re-
silience to immunosuppression (107, 138).
We think that the implications of these studies go beyond
the simple duality of emotions and immunity as an example
of body–mind continuum. Indeed, the ‘‘mirroring effect’’ that
we have proposed to explain how emotions influence immune
response and vice versa (26, 42, 43) might as well work for
another system.
There is increasing evidence that emotional state and
personality affects inflammation and OS. Interestingly, sev-
eral risk factors for CVD (high-fat diet, sedentary lifestyle,
and smoking) are associated with elevated OS, and they are
lifestyle choices associated with depression (7, 97).
Many recent studies highlighted links between outlook on
life and outcome in disease. For example, people who have
Type D personality, a pessimistic and socially inhibited
outlook, do worse during CVD. Heart failure patients with
this personality type have elevated levels of xanthine oxidase
and reduced heat shock protein 70. These factors combined
might increase OS and inflammation, leading to a worse
prognosis (89). On the other hand, higher optimism correlates
with lower levels of inflammation, IL-6, and markers of en-
dothelial dysfunction. Similarly, there is a positive correla-
tion between higher optimism scores and increased
carotenoid and antioxidant levels, which is suggestive that
optimists may have lower OS (22).
These studies might help with the stratification of patients
based on their personality traits. People who practice medi-
tation have lower levels of lipid peroxidation in serum but
higher levels of NO, which is indicative of normalized en-
dothelial function (69). The risk of all-cause mortality, stroke,
and myocardial infarction can be lowered by as much as 45%,
due to a reduction in psychosocial stress and in blood pressure,
both of which are linked to OS (151). Similarly, yoga seems to
attenuate OS, possibly by increasing glutathione reductase
(GR) and glutathione peroxidase (GPx) and by decreasing
serum lipid peroxides and F2-isoprostane. Yoga practice in
type 2 diabetics decreases MDA, increases GSH and vitamin
C, and improves glycemic control (66). However, studies
done in this area are small and, therefore, should be interpreted
with caution until larger randomized clinical trials are done.
Social isolation is an increasingly worrying threat, as so-
cially isolated people are at increased risk of several diseases,
including atherosclerosis and dementia (56, 157). Social
isolation downregulates the genes required for the GC re-
sponse, which could impair ability to dampen immune re-
sponses, and inflammation is exacerbated by increased
expression of NF-jB (38). Similarly, in rats that have been
chronically isolated, OS is observed, accompanied by de-
creased GPx and GR (49).
Opposed to social isolation, environmental enrichment
normalizes levels of TNF-a, CCL3, and CCL4 by preventing
changes in microglial expression in Alzheimer’s disease
models (184), and it lowers hippocampal damage and OS
during chronic cerebral hypoperfusion (113).
Most animal models of environmental enrichment use
physical exercise. Depressed patients who exercise have
lower markers of OS (155). In rats, GSH depletion causes
anxiety-like behavior, whereas moderate exercise on a




















































treadmill prevents OS-induced anxiety and decreases OS
markers in the hippocampus, amygdala, and the locus coer-
uleus (146).
Biomarkers of OS and inflammation
in mental disorders
There is a lot of clinical evidence to support a role of OS
and inflammation in mental disorders. Depression causes
elevated total OS in plasma and serum, with increased plasma
NO levels associated with suicidal thoughts (88, 101). De-
pressive patients are found to have lower total antioxidant
activity, with scores being indicative of poor response to
pharmacological treatments (13). A meta-analysis study
looking at C-reactive protein (CRP), IL-1, and IL-6 found
that these factors were positively correlated with depression
(75). Serum TNF-a and CRP are elevated during depression;
treatment with SSRIs returned levels to those seen in non-
depressed patients, and this was associated with decreased
clinical scores of depression (178). In social phobia patients,
studies have shown that alongside having increased MDA
there was increased SOD, GSH-Px, and catalase and lipid
peroxidation. Interestingly, a positive correlation was seen
between anxiety levels and MDA, SOD, and GSH-Px as well
as a positive correlation was seen between MDA, SOD, and
CAT and the duration of illness (10). CRP levels are elevated
in men who have anxiety disorders and are higher in those
who have late-onset anxiety disorders (>50 years), but no
difference is seen in TNF-a and IL-6 (184).
The Human Exposome
Proposed by Wild in 2005 as an environmental counterpart
to the human genome, the human exposome represents the
totality of environmental (i.e., non-genetic) exposure indi-
vidual experiences between conception and death (191). As
a ‘‘comprehensive description of lifelong exposure history’’
(192), the exposome effectively provides a new framework
for bringing together interdisciplinary teams to understand
the environmental determinants of chronic disease risk, the
influence of which are estimated to exceed those related to
genetic predisposition (144). Wild subsequently elaborated
on his definition of the exposome, emphasizing the dynamic
nature of exposures over a lifetime and categorizing com-
ponents of the exposome into three domains; internal, spe-
cific external, and general external (192).
Specific reference was made to factors that influence the
internal or cellular environment (e.g., metabolism, aging, gut
microflora activity), vary at the individual level (e.g., occu-
pation, lifestyle components, mental stress, noise, air pol-
lutants), or influence populations (e.g., climate, education,
urban/rural surroundings) (192). The definition was also ex-
panded to include behavioral interactions and products of
endogenous exposure (e.g., epigenetic changes), and to ac-
count for the cumulative nature of exposures and their cor-
responding biological adaptations (118). Although there have
been several proposed revisions of this original definition, the
practical implementation of this general concept has led re-
searchers to embrace more holistic and integrated methods
for assessing the external and internal environments.
Central to the implementation of this idea is the application
of data-dense omics techniques that report on various aspects
of the internal chemical milieu (in most cases focused on the
blood) to provide complementary datasets related to bio-
chemical status in individual biosamples. Combined with
access to mature biobanking resources, the recent radical ad-
vances in molecular biology approaches, multivariate data
analysis tools, biomonitoring technology, and the proliferation
of inexpensive mobile devices have enabled exposome studies
to become a reality.
The exposome proposal came in response to the limitations
in epidemiological studies attempting to link environmental
exposure assessments with disease endpoints—effectively
‘‘bottom-up’’ approaches, focused on a small number of
priority exposures. By contrast, exposome studies seek to
benefit from ‘‘top-down,’’ data-driven, agnostic approaches
that can uncover previously unknown and/or complex rela-
tionships, as well as guide subsequent hypothesis-based in-
vestigations to provide mechanistic insight about disease
etiology. Complete characterization of the exposome—which
would require high-resolution, real-time monitoring of all ex-
posures throughout life—is clearly unfeasible for multiple
obvious reasons (8). However, it is proposed that understanding
the status of the exposome, particularly that of the internal
chemical environment, at the individual level during critical
periods of life may help delineate the contributions of various
genetic and environmental factors.
Studying the exposome
An improved ability to characterize the external chemical
environment can enhance exposure models both spatially and
temporally, but it is the extensive characterization of an in-
ternal chemical environment that represents the most sig-
nificant advance in recent years, and an opportunity to
delineate the contributions made by multiple, interacting
factors, to the biological changes observed at an individual
level. High-throughput platforms now exist for profiling the
metabolome (metabolites), proteome (proteins), transcriptome
(gene transcripts), and adductome (typically endogenous-
xenobiotic conjugates) and they collectively provide a wealth
of information about the status of biological samples [re-
viewed in the context of the human exposome by (193),
summarized briefly in Table 2].
These platforms (mostly, now) provide broad coverage of
their biomolecular target classes, and, therefore, permit the
application of data-driven approaches that mirror those used
in the GWAS. The techniques may be performed on cells,
tissues, or biofluids, making novel biomarker selection pos-
sible for in vitro, in vivo, and human studies and integrated
analyses may be performed across the omics platforms to
cross-validate or integrate findings. Initial studies have in-
dicated that suitably collected/stored biobanked samples are
amenable to analysis by multiple omics platforms (68), and
large-scale initiatives to conduct exposome studies are now
underway [including the EXPOsOMICS (182), HELIX
(185), and HEALS projects in the EU].
Unpicking the exposome: cellular inflammatory
responses to DEP
Although there is considerable activity in molecular epi-
demiological analysis to characterize biological samples
archived in biobanks, the validation and mechanistic under-
standing that accompanies these largely correlative analyses is
both complementary and vital; tying together evidence from




















































multiple levels of analysis is required to corroborate the cor-
relative analyses that are conducted on these omics readouts
(144, 182). For example, although many of the ongoing ex-
posome studies include aspects regarding air pollutants, vali-
dation of these studies requires a coherent molecular context,
whereas conversely targeted analyses need to be directed ap-
propriately. For example, DEP are considered important envi-
ronmental causes of OS and pulmonary inflammation due to
their ubiquitous presence in air (84), their concentration in
populated areas (206), and the breadth of sub-populations that
are susceptible to their inflammatory and oxidative effects (12,
17, 27, 37, 53).
Adverse responses to DEP exposure have traditionally
been assessed by quantifying specific inflammatory cells,
cytokines, or cell adhesion molecules (CAM) after exposures
(2, 93, 127, 152, 175). These targets are well-characterized
mediators of inflammation that provide strong evidence of
DEP induction of inflammatory cellular response, but they
are limited in their potential to expand our mechanistic
knowledge of the observed toxicity. In contrast, agnostic
approaches for omics screening report on both characterized
and uncharacterized markers, offering chances to explore a
wider range of associations with DEP toxicity. Xiao et al.
used a proteomic screening approach, showing that DEP in-
duced OS in RAW 264.7 macrophages; the response was ac-
companied by more than eightfold increases in new protein
expression. Furthermore, the biological functions of the proteins
reflected a hierarchical response to OS, with the macrophages
expressing antioxidant enzymes after low-dose exposures
(£10lg/ml), pro-inflammatory signaling proteins after mid-
dose exposures (10–50lg/ml), and regulators of mitochondrial
function at cytotoxic doses (‡50 lg/ml) (198). Although many
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of these proteomic changes validated existing hypotheses of
how macrophages respond to DEP, others (including the in-
duction of receptor-induced apoptosis) were previously un-
characterized (198). These changes revealed novel pathways
that are triggered by DEP-induced OS, advancing our under-
standing of the response.
Metabolomic, transcriptomic, and proteomic profiles are
strongly dependent on the expression and behavior of the
other molecular species as well as experience a dynamic in-
teraction with the external chemical environment (Fig. 7).
Proteomic responses to DEP-induced OS (198) are mirrored
by transcriptomic studies showing changed expression of
oxidative response genes after DEP exposure (91, 134) as
well as micro RNA (79).
Supporting the hypothesis that surface-bound metals and
polycyclic aromatic hydrocarbons (PAHs) contribute to
particulate toxicity (87, 135), metal and PAH-rich heavy fuel
oil particles induce inflammatory and OS pathways more than
carbonaceous DEP (130).
Redox status, inflammation, and ROS are all intricately
linked with biotransformation of compounds across this
continuum. For example, dietary components have been
linked with modulation of cytokine levels, with a concomi-
tant impact on the metabolome (36), with other recent ex-
amples including herbal medicine (205), involvement in
arthritis [reviewed by Chimenti et al. (31)], and broader
implication in pathways identified by cross-omics analysis
(16, 163). In addition, a comprehensive survey focused on the
role of metabolome studies in characterizing oxidative
studies was previously published by Liu et al. (108).
Exposome and adverse outcome pathways:
inflammation and ROS are key integrators of complex
exposure-response relationships
One exemplar that elegantly illustrates the interplay of
inflammatory mediators and ROS with other components of
the internal chemical milieu is the analgesic/antipyretic
compound paracetamol (also known as acetaminophen), one
of the most commonly used over-the-counter drugs world-
wide. Self-administration is the main cause for personal ex-
posure (exposure in the wider environment is negligible), and
large-scale, cross-sectional metabolic phenotyping studies
of humans have shown a high prevalence of significant (e.g.,
therapeutic dose) exposure (109, 110).
Characterization of population-level use of therapeutics
(e.g., anti-inflammatory agents) provides an overall profile of
the exposome, and it helps contextualize and validate observed
responses at the individual level (e.g., when addressing re-
search questions related to chronic inflammation that may be
confounded by unreported pharmaceutical use). Intense scru-
tiny has allowed many of the toxicological consequences of
paracetamol exposure and metabolism to be elucidated (in-
cluding depletion of cellular antioxidants, increased ROS
formation, and formation of reactive intermediates).
However, despite such widespread, long-term, and con-
sistent use, the complexities of the exposure-response rela-
tionship continue to be uncovered (including metabolite
conjugation to arachidonic acid to produce an active metab-
olite AM404 (72) and metabolite modulation of the noci-
ceptive response (4)). This also illustrates the challenge that
FIG. 7. Interactions between genes and the environment are mediated by a complex network of biological entities.
Environmental exposures occur in the context of all previous exposures and the multifactorial responses elicited by the
biological network. Characterization of the biological complexity of the internal chemical milieu during key periods of life
(e.g., small molecules that constitute the metabolic phenotype; status of gene expression; etc.) by using high-throughput
omics platforms provides a window on the human exposome, and an opportunity to start dissecting the contributions of
various factors to the etiology of chronic diseases.




















































is faced when considering how to dissect the complex, mul-
ticomponent exposures that occur throughout life; consider-
ations of additive or non-linear effects arising from co-
exposures all add up.
Attempts to bring together the diverse pieces of evidence
that relate to exposure-response-disease relationships, and to
address the challenge of this inherent complexity have re-
sulted in the formulation of systems toxicology tools such as
adverse outcome pathways (AOPs), as summarized by Bur-
den et al. (28). By establishing a series of causal steps from an
initial molecular initiating event onward, the AOP approach
may help integrate knowledge about multiple environmental
exposures that share common pathways, described by using
an agreed ontology. The combination of the exposome and
AOP frameworks is likely to be particularly useful when the
complexity of exposure-response relationships is considered;
exposures do not occur in isolation, but in a context that
encodes previous exposures and responses, and they mediate
the dynamic relationship between co-exposures.
In the context of OS, several redox proteomics techniques
and their application to the field of inflammation and neuroin-
flammation have led to the identification of specific oxidized
proteins undergoing carbonylation (170) or glutathionylation
(30, 122). The extension of omics to oxidative post-translational
modifications may add a dimension to the information obtained
and eventually provide a more precise way of identifying ex-
posure to agents that cause OS.
The strong underlying biological network connections be-
tween certain sets of pathologies—particularly those related to
systemic inflammatory status that underpin multiple chronic
disease conditions—may mean that we move away from at-
tempts to find correspondence between individual exposures
and outcomes, and toward using biological networks to link
and explain complex exposure patterns with (multi)morbidities
defined by detailed molecular phenotyping (102, 169).
Conclusions
The use of biomarkers of inflammation or OS has been
instrumental to formulating causal hypotheses on disease
mechanisms (such as the effect of environmental stressors).
We mentioned earlier that, in a way, biomarkers are signs.
However, there are different types of signs and so, if bio-
markers are really signs in a non-metaphorical sense, there
must be different types of biomarkers as well, depending on
the relationship they have with their referent. In fact, we do
not just measure biomarkers; in some cases, we can measure
the ‘‘real thing.’’
For instance, to quantify exposure to heavy metals, we can
measure their level in the organism. When this is not possible,
we can measure signs that are indicators of the exposure of
the body to heavy metals. Some of them have a direct rela-
tionship to the object; for example, a product of lipid per-
oxidation is directly formed by a chemical reaction between
an ROS and a lipid. Others can be an indicator of the response
of the organism to the object that we want to measure, and
this is the case of NRF2 or the markers of exposure described
in the section on the exposome; all these will have various
degrees of separation from the object that we want to mea-
sure, and this needs to be considered as some may require just
transcription (if we measure an mRNA), others transcription,
and translation (if we measure a protein).
This is particularly important if we are measuring exposure
to a physical stressor, such as noise, or a psychological
stressor, that is not present at the time of the examination.
Interestingly, even if not obvious, inflammation itself is a
response to a foreign body or to an endogenous or exogenous
stressor. It is important to note that measuring biomarkers is
not always a second, imperfect choice when we cannot mea-
sure what we need (like in the case of short-lived radicals).
Often, measuring a biological response adds a second dimen-
sion, that of biological relevance. But in the case of inflam-
matory biomarkers, we observe a further level of relevance.
Let us consider inflammatory cytokines. As mentioned ear-
lier, they are easily measurable biomarkers of inflammation,
many of which are measurable in plasma or serum. However,
some of them are not simple signs but proxies. A proxy of
something is a sign that has a vicarious relationship with that
something: It both ‘‘stands for’’ its referent and ‘‘stands in for’’ it.
This means that not only there is a link between proxy and
referent; but one can also interact with the referent by oper-
ating on the proxy and, as a result, affect the object (or pro-
cess, in this case) that it stands for (55). In short, they have a
bidirectional relationship with the referent. If MDA is ele-
vated in a disease because of increased lipid peroxidation,
you cannot improve the disease by administering an anti-
MDA antibody, because it is just a sign of OS.
However, in inflammatory diseases, IL-6 and TNF-a are not
only signs of the inflammatory process but also proxies, and so
their inhibition, for instance with antibodies, improves the
disease in patients with chronic inflammation. This concept is
exemplified in Figure 8, where the mediators and processes
described in this article are assigned a value of biomarkers
(considering their ease of measurement) or proxies.
Researchers often classify biomarkers differently. For in-
stance, MDA, IL-6, and TNF would be considered mechanism-
based biomarkers because they reflect a potential disease
mechanism. On the other hand, IL-6 and TNF are also defined
as ‘‘pharmacological targets,’’ although not all pharmacolog-
ical targets are biomarkers as some of them are not measurable.
The definition of biomarkers as signs and their value, whether
they are proxies or just signs, will need to be considered when
considering their role in disease.
FIG. 8. Biomarkers for stress-induced inflammation
and OS. The symbols denote whether the biomarker is a
sign (that indicates the activation of a process) or a proxy
(that are also targets we can interact with to modify the
disease process).
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Abbreviations Used
AOP¼ adverse outcome pathway
ARE¼ antioxidant response element
BMDM¼ bone marrow-derived macrophages





DEP¼ diesel exhaust particles
ENM¼ engineered nanomaterials





GSK-3¼ glycogen synthase kinase 3
GSSG¼ oxidized glutathione
GWAS¼ genome-wide association studies
HNE¼ 4-hydroxy 2,3-nonenal
HPAA¼ hypothalamus-pituitary-adrenal axis
IHC¼ inner hair cells
IL¼ interleukin
iNOS¼ inducible nitric oxide synthase





NF-jB¼ nuclear factor kappa B
NIHL¼Noise-induced hearing loss
NLP3¼NACHT, LRR and PYD
domains-containing protein 3
NRF2¼ nuclear factor (erythroid-
derived 2)-like 2
NT¼ nitrotyrosine
OHC¼ outer hair cells
OS¼ oxidative stress
P2X7R¼ purinergic receptor P2X7
PAH¼ polycyclic aromatic hydrocarbons
PM¼ particulate matter
PRDX¼ peroxiredoxin
PTEN¼ phosphatase and tensin homolog
PTSD¼ post-traumatic stress disorder
RNS¼ reactive nitrogen species
ROS¼ reactive oxygen species
SOD¼ superoxide dismuates
SPL¼ sound pressure level
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